Abstract
Insulin resistance is said to exist whenever normal concentrations of insulin produce a less-than-normal biological response (Kahn, 1978). In humans, insulin resistance is usually defined by the presence of hyperinsulinemia in the face of normal or elevated blood sugar or by resistance to exogenous insulin. Insulin resistance may occur in a large number of different disease states. The most frequent causes of mild to moderate insulin resistance are obesity and maturity-onset, insulin-independent diabetes (Olefsky, 1981). This chapter will consider two of the rare forms of insulin resistance: the syndrome of insulin resistance due to antireceptor antibodies and insulin resistance due to insulin antibodies. In both of these the patients are severely insulin-resistant and frequently fail to respond to 10 or even 1000 times or more the normal therapeutic dose of insulin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akre, P. R. Kirtley, W. R., and Galloway, J. A., 1964, Comparative hypoglycemic response of diabetic subjects to human insulin or structurally similar insulins of animal sources, Diabetes 13: 135–143.
Andersen, O. O., 1973, Insulin antibody formation. H. The influence of species difference and method of administration, Acta Endocrinol. (Copenh.), 72: 33–45.
Bar, R. S., Levis, W. R., Rechler, M. M., Siebert, C. W., Podskalny, J. M., Roth, J., and Muggeo, M., 1978, Extreme insulin resistance in ataxia telangiectasia: Defect in affinity of insulin receptors. N. Engl. J. Med. 298: 1164–1171.
Bar, R. S., Muggeo, M., Kahn, C. R., Gorden, P., and Roth, J., 1980, Characterization of the insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans, Diabetologia 18: 209–216.
Belsham, G. J., Browney, R. W., Hughes, W. A., and Denton, R. M., 1980, Anti-insulin receptor antibodies mimic the effects of insulin on the activities of pyruvate dehydrogenase and acetyl CoA carboxylase and a specific protein phosphorylation in rat epididymal fat cells, Diabetologia 18: 307–312.
Berson, S. A., and Yalow, R. S., 1959, Quantitative aspects of reaction between insulin and insulin-binding antibody, J. Clin. Invest. 38: 1996–2016.
Berson, S. A., and Yalow, R. S., 1966, Insulin in blood and insulin antiobodies, Am. J. Med. 40: 676–690.
Berson, S. A., and Yalow, R. S., 1970, Insulin “antagonists” and insulin resistance. Diabetes Mellitus: Theory and Practice (M. Ellenberg and H. Rifkin, eds.), pp 388–422, McGraw-Hill, New York
Bertrams, J., Jansen, F. K., Gruneklee, D., Reis, H. E., Drost, H., Beyer, J., Gries, F. A., and Kuwert, E., 1976, HLA antigens and immunoresponsiveness to diabetes mellitus, Tissue Antigens 8: 13–19.
Bloom, S. R., Adrian, T. E., Barnes, A. J., and Polak, J. M., 1979, Autoimmunity induced by hormonal contaminants of insulin, Lancet, 1: 14–17.
Blundell, T. L., Dodson, G. C., Hodgkin, D. C., and Mercola, D. A., 1972, Insulin: Structure in the crystal and its reflection in chemistry and biology, Adv. Protein Chem. 26: 279–402.
Boshell, B. R., Barrett, J. C., Witensky, A. S., and Patton, T. B., 1964, Insulin resistance: Response to insulin from various animal sources including human, Diabetes 13: 144–152.
Chance, R. E., Root, M. A., and Galloway, J. A., 1976, The immunogenicity of insulin preparations, Acta Endocrinol. (Copenh.) 83 (Suppl. 205): 185–196.
Davidson, J. K., and De Bra, D. W., 1978, Immunologic insulin resistance, Diabetes 27:307–318. DeMeyts, P., Bianco, A. R., and Roth, J., 1976, Site-site interactions among insulin receptors: Characterization of the negative cooperativity, J. Biol. Chem. 251: 1877–1888.
deShazo, R. D., 1978, Insulin allergy and insulin resistance. Two immunologic reactions, Postgrad. Med. 63: 85–92.
Flier, J. S., Kahn, C. R., Roth, J., and Bar, R. S., 1975, Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance, Science 190: 63–65.
Flier, J. S., Kahn, C. R., Jarrett, D. B., and Roth, J., 1976, Characterization of anti-insulin receptor antibodies: A cause of insulin resistant diabetes in man, J. Clin. Invest. 548: 1442–1449.
Flier, J. S., Kahn, C. R., Jarrett, D. B., and Roth, J., 1977, Autoantibodies to the insulin receptor: Effect on the insulin-receptor interaction in IM-9 lymphocytes, J. Clin. Invest. 60: 784–794.
Flier, J. S., Barf R. S., Muggeo, M., Kahn, C. R., Roth, J., and Gorden, P., 1978, The evolving clinical course of patients with insulin receptor antibodies: spontaneous remission or receptor proliferation with hypoglycemia, J. Clin Endocrinol. Metab. 47: 985–995.
Freychet, P., Kahn, C. R., Roth, J., Neville, D. M., Jr.,1972, Insulin interactions with liver plasma membranes: Independence of binding and degradation, J. Biol. Chem. 247: 3953–3961.
Galloway, J. A., and Bressler, R., 1978, Insulin treatment in diabetes. Med. Clin North Am., 62: 663–680.
Gavin, J. R., III, Roth, J., Neville, D. M., Jr., DeMeyts, P., and Buell, D. N., 1974, Insulin-dependent regulation of insulin receptor concentrations: A direct demonstration in cell culture, Proc. Natl. Acad. Sci. USA, 71: 84–88.
Ginsberg, B. H., Kahn, C. R., Roth, J., and DeMeyts, P., 1976, Insulin-induced dissociation of its receptor into subunits: possible molecular concomitant of negative cooperativity, Biochem. Biophys. Res. Commun. 73: 1068–1074.
Gorden, P., Carpentier, J. L., Freychet, P., and Orci, L., 1980, Internalization of polypeptide hormones: Mechanism, intracellular localization and significance, Diabetologia 18: 263–274.
Green, I., Paul, W. E., and Benacerraf, B., 1966, The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responder and as haptens in nonresponder guinea pigs, J. Exp. Med. 123: 859–879.
Grunfeld, C., Van Obberghen, E., Karlsson, F. A., and Kahn, C. R., 1980, Antibody-induced desensitization of the insulin receptor: Studies of the mechanism of desensitization in 3T3–L1 fatty fibroblasts, J. Clin. Invest. 66: 1124–1134.
Hannon, J. T., Kahn, C. R., Kempner, E. J., and Schlegel, W., 1980, Characterization of the insulin receptor in its membrane environment by radiation inactivation, J. Biol. Chem. 255: 3412–3419.
Harrison, L. C., and Itin, A., 1979, A possible mechanism for insulin resistance and hyperglycemia in NZO mice, Nature (Lon.) 279: 334–336.
Harrison, L. C., Muggeo, M., Bar, R. S., Flier, J. S., Waldman, T., and Roth, J., 1979a, Insulin binding defects induced by a serum globulin factor in ataxia telangectasia, Clin. Res. 27: 252A.
Harrison, L. C., Flier, J. S., Roth, J., Karlsson, F. A., and Kahn, C. R., 1979b, Immunoprecipitation of the insulin receptor: A sensitive assay for receptor antibodies and a specific technique for receptor purification, J. Clin. Endocrinol. Metab. 48: 59–65.
Hedo, J., Kasuga, M., Van Obberghen, E., Roth, J., and Kahn, C. R., 1981, Direct demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labeling: Evidence for heterogeneity, Proc. Natl. Acad. Sci., USA 78: 4791–4795.
Jarrett, D. B., Roth, J., Kahn, C. R., and Flier, J. S., 1976, Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-anti-receptor autoantibodies. Proc. Natl. Acad. Sci. USA 73: 41154119.
Kahn, C. R., 1978, Insulin resistance, insulin insensitivity and insulin unresponsiveness: A necessary distinction, Metabolism 27 (suppl. 2): 1893–1902.
Kahn, C. R., and Harrison, L. C., 1980, Insulin receptor antibodies, in: Carbohydrate Metabolism and its Disorders ( P. J. Randle, D. F. Steiner, and W. J. Whelan, eds.), pp. 279–330, Academic Press, London.
Kahn, C. R., and Rosenthal, A. S., 1979, Immunologic reactions to insulin: Insulin allergy, insulin resistance and the automimmune insulin syndrome, Diabetes Care 2: 283–295.
Kahn, C. R., Flier, J. S., Bar, R. S., Archer, J. A., Gorden, P., Martin, M. M., and Roth, J., 1976, The syndromes of insulin resistance and acanthosis nigricans: Insulin receptor disorders in man, N. Engl. J. Med. 294: 739–745.
Kahn, C. R., Megyesi, K., Bar, R. S., Eastman, R. C., and Flier, J. S., 1977a, Receptors for peptide hormones: New insights into the pathophysiology of disease states in man, Ann. Intern. Med. 86: 205–219.
Kahn, C. R., Baird, K. L., Flier, J. S., and Jarrett, D. B., 1977b, Effect of autoantibodies to the insulin receptor on isolated adipocytes: Studies of insulin binding and insulin action, J. Clin. Invest. 60: 1094–1106.
Kahn, C. R., Baird, K. L., Jarrett, D. B., and Flier, J. S., 1978, Direct demonstration that receptor cross-linking or aggregation is important in insulin action, Proc. Natl. Acad. Sci. USA 75: 4209.
Kahn, C. R., Harrison, L. C., Flier, J. S., Muggeo, M., Van Obberghen, E., Grunfeld, C., Karlsson, F. A., King, G. L., and Roth, J., 1980, Antibodies to the insulin receptor and insulin resistant diabetes, in: Autoimmune Aspects of Endocrine Disorders ( A. Pinchera, D. Domach, G. F. Fenzi, and L. Baschieri, eds.); pp. 275–280, Academic Press, London.
Kahn, C. R., Baird, K. L., Hier, J. S., Grunfeld, C., Harmon, J. T., Harrison, L. C., Karlsson, F. A., Kasuga, M., King, G. L., Lang, U. C., Podskalny, J. M., and Van Obberghen, E. M., 1981, Insulin receptors, receptor antibodies, and the mechanism of insulin action, Rec. Prog. Norm. Res. 37: 477–532.
Kahn, C. R., Mann, D. L., Rosenthal, A. S., Galloway, J. A., Johnson, A. H., and Mendell, N., 1982, The immune response to insulin in man. Interaction of HLA alloantigens and the development of the immune response, Diabetes 31: 716–723.
Karlsson, F. A., Van Obberghen, E., Grunfeld, C., and Kahn, C. R., 1979, Desensitization of the insulin receptor at an early post-receptor step by prolonged exposure to anti-receptor antibody, Proc. Natl. Acad. Sci. USA 76: 809–813.
Kasuga, M., Akanuma, U., Tsushima, T., Suzuki, K., Kosaka, K., and Kibata, M., 1978, Effects of anti-insulin receptor autoantibody in the metabolism of rat adipocytes, J. Clin. Endocrinol. Metab. 47: 66–77.
Kasuga, M., Kahn, C. R., Hedo, J. A., Van Obberghen, E., and Yamada, K. M., 1981, Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation, Proc. Natl. Acad. Sci. USA 78: 6917–6921.
Kasuga, M., Karlsson, F. A., and Kahn, C. R., 1982, Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor, Science 215: 185–187.
Kawanishi, K., Kawamura, K., Nishina, A. G., Okada, S., Ishide, T., Ohiji, T., Kahn, C. R., and Flier, J. S., 1977, Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies, J. Clin. Endocrinol. Metab. 44: 15–21.
King, G. L., Kahn, C. R., Rechler, M. M., and Nissley, S. P., 1980, Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor, J. Clin. Invest. 66: 130–140.
Lang, U. C., Kahn, C. R., and Chrombach, A., 1980, Characterization of the insulin receptor and insulin-degrading activity from human lymphocytes by quantitative polyacrylamide gel electrophoresis, Endocrinology 106: 40–49.
Lawrence, J. C., Jr., Lamer, J., Kahn, C. R., and Roth, J., 1978, Autoantibodies to the insulin receptor activate glycogen synthase in rat adipocytes, Mol. Cell. Biochem. 22: 153–158.
Little, J. A., and Amott, J. H., 1966, Sulfated insulin in mild, moderate, severe, and insulin-resistant diabetes mellitus, Diabetes 15: 457–465.
Ludvigsson, J., Safwenberg, J., and Heding, L. G., 1977, HLA-types, C-peptide and insulin antibodies in juvenile diabetes, Diabetologia 13: 13–17.
Massague, J., Pilch, P. F., and Czech, M. P., 1980, Electrophoretic resolution of three major insulin recep- tor structures with unique subunit stiochiometries, Proc. Natl. Acad. Sci. USA 77: 7137–7141.
Muggeo, M., Ginsberg, B. H., Roth, J., Neville, D. M., Jr., DeMeyts, P., and Kahn, C. R., 1979a, The insulin receptor is functionally more conserved during evolution than insulin itself, Endocrinology 104: 1393–1402.
Muggeo, M., Flier, J. S., Abrams, R. A., Harrison, L. C., Deisseroth, A. B., and Kahn, C. R., 1979b, Treatment by plasma exchange of a patient with autoantibodies to the insulin receptor, N. Engl. J. Med. 300: 477–480.
Muggeo, M., Kahn, C. R., Bar, R. S., Rechler, M. M., Flier, J. S., and Roth, J., 1979c, The underlying insulin receptor in patients with antireceptor antibodies: Demonstration of normal binding and immunological properties, J. Clin. Endocrinol. Metab. 49: 110–119.
Olefsky, J. M., 1981, Insulin resistance and insulin action: An in vitro and in vivo perspective, Diabetes 30: 148–162.
Patterson, R., O’Rourke, J., Robert, M., and Suszko, I., 1973a, Immunologic reactions against insulin. I. IgG anti-insulin and insulin resistance, J. Immunol. 110: 1126–1134.
Patterson, R., Mellies, C. J., and Roberts, M., 1973b, Immunologic reactions against insulin. II. IgE anti-insulin, insulin allergy and combined IgE and IgG immunologic insulin resistance, J. Immunol. 110: 1135–1145.
Reeves, W. G., 1980, Immunology of diabetes and insulin therapy, Recent Adv. Clin. Immunol. 2: 183–220.
Rosenthal, A. S., 1978, Determinant selection and macrophage function in genetic control of the immune response, Immunol. Rev. 401: 36–152.
Schemthaner, G., Ludwig, H., Mayr, W. R., and Frish, H., 1977, Evidence for genetic control of anti-insulin immunity in juvenile onset diabetes mellitus, Diabetes Metab. 3: 117–121.
Schlessinger, J., Van Obberghen, E., and Kahn, C. R., 1980, Insulin and antibodies against the insulin receptor cap on the membrane of cultured human lymphocytes, Nature 286: 729–731.
Serge, K., and Peterson, P. A., 1978, Use of anti-idiotypic antibodies as cell-surface receptor probes, Proc. Natl. Acad. Sci. USA, 75: 2443–2447.
Shechter, Y., Chang, K. J., Jacobs, S., and Cuatrecas, P., 1979, Modulation of binding and bioactivity of insulin by anti-insulin antibody: Relation to possible role of receptor self-aggregation in hormone action, Proc. Natl. Acad. Sci. USA 76: 2720–2724.
Shechter, Y., Maron, R., Elias, D., and Cohen, I. R., 1982, Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin, Science 216: 542–544.
Shipp, J. C., Cunningham, R. W., Russell, R. O., and Marble, A., 1967, Insulin resistance: Clinical features, natural course and effects of adrenal steroid treatment, Medicine 44: 165–186.
Van Obberghen, E., Kasuga, M., Lelam, A., Hedo, J. A., Itin, A., and Harrison, L. C., 1981, Biosynthetic labeling of insulin receptor: Studies of subunits in cultured human IM-9 lymphocytes, Proc. Natl. Acad. Sci. USA 78: 1052–1056.
Yip, C., Yeung, C. W. T., and Mark, M. L., 1980, Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations, Biochemistry 19: 70–76.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Publishing Corporation
About this chapter
Cite this chapter
Kahn, C.R. (1984). Antibodies to Insulin and Insulin Receptors: Mechanisms of Insulin Resistance. In: Gupta, S. (eds) Immunology of Clinical and Experimental Diabetes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4559-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4559-6_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4561-9
Online ISBN: 978-1-4684-4559-6
eBook Packages: Springer Book Archive